InChI=1S/C21H33N3O6S2/c1-4-12(2)19-16(25)10-18(27)30-14-7-5-6-8-31-32-11-15(21(29)24-19)23-20(28)13(3)22-17(26)9-14/h5,7,12-16,19,25H,4,6,8-11H2,1-3H3,(H,22,26)(H,23,28)(H,24,29)/b7-5+/t12-,13+,14+,15+,16-,19+/m0/s1 |
MJHZJODQLYCXHE-WXZCCWHXSA-N |
C1SSCCC=C[C@@H]2CC(N[C@@](C(N[C@H]1C(N[C@@]([C@H](CC(O2)=O)O)([C@H](CC)C)[H])=O)=O)(C)[H])=O |
|
Pseudomonas
(NCBI:txid286)
|
isolated from culture broth
See:
Y. Masuoka, A. Nagai, K. Shin-ya, K. Furihata, K. Nagai, K. Suzuki, Y. Hayakawa, H. Seto, Tetrahedron Lett. 2001 , 42 , 41–44
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
EC 3.5.1.98 (histone deacetylase) inhibitor
An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the function of histone deacetylase (EC 3.5.1.98).
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1S,5S,6R,9S,15E,20R)-6-[(2S)-butan-2-yl]-5-hydroxy-20-methyl-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docos-15-ene-3,8,18,21-tetrone
|
(−)-spiruchostatin B
|
ChEBI
|
18598407
|
Reaxys Registry Number
|
Reaxys
|
18368162
|
PubMed citation
|
Europe PMC
|
19333864
|
PubMed citation
|
Europe PMC
|
19760730
|
PubMed citation
|
Europe PMC
|
21445425
|
PubMed citation
|
Europe PMC
|
22211246
|
PubMed citation
|
Europe PMC
|
25078973
|
PubMed citation
|
Europe PMC
|
|